Skip to content
Bristows
  • Expertise

    Core sectors

    • Life sciences
    • Technology
    • Brands

    Litigation & dispute resolution (Archive)

    • Advertising & marketing
    • Arbitration
    • Artificial intelligence
    • Charities and not-for-profit
    • Commercial & IP transactions
    • Competition advice & investigations
    • Competition litigation
    • Confidential information & trade secrets disputes
    • Corporate & financing
    • Cyber & data breaches

    Transactions

    • Data protection & privacy
    • Defamation & privacy disputes
    • Employment & immigration
    • Freedom to operate
    • IT & digital projects
    • IT disputes
    • Life sciences disputes
    • Life sciences regulatory
    • Litigation & dispute resolution
    • Merger control
    • Open source

    Regulatory & advisory

    • Outsourcing
    • Patent litigation
    • Real estate
    • SEP/FRAND disputes
    • Tax
    • Technology regulation
    • Telecommunications
    • Trade mark, designs & copyright disputes
    • Trade mark & design portfolio management
    • UPC
  • Viewpoint
    • Articles
    • Events
    • Latest news
    • Podcasts
    • Publications
  • People
  • Careers
    • Apprentices
    • Current opportunities
    • Diversity, Equality & Inclusion
    • Life at Bristows
    • Trainees
  • About us
    • Alumni
    • A reputation for firsts
    • Awards and recognitions
    • Compliance information
    • Corporate responsibility
    • GDPR
    • International horizon
    • Our locations
    • Our values
  • Contact
  1. Home
  2. On the Pulse
  3. Patent Review of the Year

Patent Review of the Year

12.04.2017

Bristows’ Patent Review of the Year reports each year on important decisions from both the High Court and the Court of Appeal, particularly with regards to the law of obviousness and certain procedural issues.

If you would like to receive a hard copy of Bristows’ Patent Review of the Year, contact us HERE.

Share

  • Facebook
  • Twitter
  • LinkedIn

Practices

  • Patent litigation
Related news
  • Human embryo research: should we re-draw the line?
    09.11.2023
  • Is the end near for UKCA marks for medical devices?
    14.08.2023
  • The present and future of SESG for biopharmaceutical companies
    16.06.2023
  • UK MDR amending legislation heralds arrival of new medical device framework
    24.05.2023
  • DNA sequencing by synthesis patents held valid and infringed
    03.05.2023
  • Under the antitrust spotlight: (mis)use of patents in the pharma sector
    12.04.2023
Back to articles
  • linkedin
  • youtube
  • instagram
(SRA Number 591711)
Bristows LLP
London:

100 Victoria Embankment
London EC4Y 0DH
T +44 20 7400 8000
DX 269

Brussels:

Avenue des Arts 56 
1000 Bruxelles 
Belgium 
T +32 2 808 7500 

Dublin:

18-20 Merrion St Upper
Dublin 2 , D02 XH98
Ireland
T +353 1 270 7755

RSS feeds
  • News and publications
  • Events and seminars
Other links
  • Bristows Trainees site
  • Accessibility
  • Compliance information
  • Cookie policy
  • Modern slavery act
  • Terms of use
2026 Bristows LLP Website by Itineris